- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-02-0034249

Nuverdure Pharmaceuticals Private Limited
About Nuverdure Pharmaceuticals Private Limited
Data last updated:
Nuverdure Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 14 June 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC399916.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikrant Tomar and Pawan Kumar Singh.
Its last annual general meeting (AGM) was held on 30 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B – 23/24 3rd Floor Kh No – 7/19 Gali No – 11 Mukund Vihar Karawal Nagar, Delhi, India – 110090.
Nuverdure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0034249). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Nuverdure Pharmaceuticals
Contact details
Nuverdure Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressB – 23/24 3rd Floor Kh No – 7/19 Gali No – 11 Mukund Vihar Karawal Nagar, Delhi, India – 110090
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nuverdure Pharmaceuticals Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nuverdure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nuverdure Pharmaceuticals Private Limited
Nuverdure Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikrant Tomar | Director | 14 Jun 2022 | 4 Years 5 Months | Current |
| Pawan Kumar Singh | Director | 14 Jun 2022 | 4 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Nuverdure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuverdure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nuverdure Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nuverdure Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Pawan Kumar Singh was appointed as Director on 14 Jun 2022.
Frequently asked questions
Nuverdure Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 14 June 2022 (4+ years old) and is registered under CIN U51909DL2022PTC399916.
Nuverdure Pharmaceuticals has 2 current directors:
- Vikrant Tomar - Director
- Pawan Kumar Singh - Director
The latest financial statements of Nuverdure Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 December 2023. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Nuverdure Pharmaceuticals is U51909DL2022PTC399916. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuverdure Pharmaceuticals was incorporated on 14 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Pawan Kumar Singh was appointed as Director on 14 Jun 2022. Vikrant Tomar was appointed as Director on 14 Jun 2022.
Yes, Nuverdure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0034249).
The registered office of Nuverdure Pharmaceuticals is at B – 2324 3rd Floor Kh No – 719 Gali No – 11 Mukund Vihar Karawal Nagar, Delhi, India – 110090.
Nuverdure Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Nuverdure Pharmaceuticals is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.

